Login / Signup

Physiologically-based pharmacokinetics of ziprasidone in pregnant women.

Carla BiesdorfFrederico Severino MartinsSherwin K B SyAndrea Diniz
Published in: British journal of clinical pharmacology (2019)
The PBPK model predicted the impact of physiological changes during pregnancy on PK and exposure of ziprasidone, suggesting that dose adjustment is not necessary in this special population.
Keyphrases
  • pregnant women
  • pregnancy outcomes